Antibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-115530 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- MACC1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide
- Description
- Antibody detects endogenous levels of total MACC1.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 100 µL
- Concentration
- 1 mg/mL
- Storage
- -20°C
Submitted references miR-199b-3p contributes to acquired resistance to cetuximab in colorectal cancer by targeting CRIM1 via Wnt/β-catenin signaling.
Han H, Li Y, Qin W, Wang L, Yin H, Su B, Yuan X
Cancer cell international 2022 Jan 28;22(1):42
Cancer cell international 2022 Jan 28;22(1):42
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Fig. 6 AntagomiR-199b-3p enhances the efficacy of CTx on CRC-CTxR tumor growth in vivo. After cell inoculation for a week, the volume of xenograft tumors in each group was recorded every five days (days 7, 12, 17, 22, 27, 32, and 37), A Growth curve and B representative images of xenograft tumors from each group. Tumor weights and D volume were recorded at the end of the experiments. E IHC staining determined the protein expression of Ki-67 and MACC1 in xenograft tumors (Scale bars: 100 mum). *P < 0.05 and ***P < 0.005 compared with saline group; ### P < 0.005 compared with CTx group